368 related articles for article (PubMed ID: 30037856)
1. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished
Kulkarni P; Dasgupta P; Bhat NS; Shahryari V; Shiina M; Hashimoto Y; Majid S; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
Mol Cancer Res; 2018 Nov; 16(11):1750-1760. PubMed ID: 30037856
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
Zhang YJ; Lu C
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
[TBL] [Abstract][Full Text] [Related]
3. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.
Chen Z; Zhang J; Zhang Z; Feng Z; Wei J; Lu J; Fang Y; Liang Y; Cen J; Pan Y; Huang Y; Zhou F; Chen W; Luo J
Cell Death Dis; 2017 Jun; 8(6):e2859. PubMed ID: 28569782
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
Ye Y; Zhang F; Chen Q; Huang Z; Li M
Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
[TBL] [Abstract][Full Text] [Related]
5. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.
Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G
Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285
[TBL] [Abstract][Full Text] [Related]
6. LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis.
Zhou X; Zeng B; Li Y; Wang H; Zhang X
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834139
[TBL] [Abstract][Full Text] [Related]
7. Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction.
Chen S; Ma P; Zhao Y; Li B; Jiang S; Xiong H; Wang Z; Wang H; Jin X; Liu C
J Physiol Sci; 2017 Sep; 67(5):577-585. PubMed ID: 27655020
[TBL] [Abstract][Full Text] [Related]
8. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation.
Qi Y; Ma Y; Peng Z; Wang L; Li L; Tang Y; He J; Zheng J
Oncogene; 2020 May; 39(22):4404-4420. PubMed ID: 32341409
[TBL] [Abstract][Full Text] [Related]
10. lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.
Zhu K; Miao C; Tian Y; Qin Z; Xue J; Xia J; Zhu S; Xu A; Yang J; Wang Z
J Cell Mol Med; 2020 Sep; 24(17):10013-10026. PubMed ID: 33460239
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
Dasgupta P; Kulkarni P; Majid S; Shahryari V; Hashimoto Y; Bhat NS; Shiina M; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
Mol Cancer Ther; 2018 May; 17(5):1061-1069. PubMed ID: 29440295
[TBL] [Abstract][Full Text] [Related]
12. A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.
Kulkarni P; Dasgupta P; Hashimoto Y; Shiina M; Shahryari V; Tabatabai ZL; Yamamura S; Tanaka Y; Saini S; Dahiya R; Majid S
Cancer Res; 2021 Mar; 81(6):1500-1512. PubMed ID: 33500248
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma.
Qu Y; Xiao H; Xiao W; Xiong Z; Hu W; Gao Y; Ru Z; Wang C; Bao L; Wang K; Ruan H; Song Z; Chen K; Zhang X; Yang H
Cell Physiol Biochem; 2018; 48(3):1075-1087. PubMed ID: 30041179
[TBL] [Abstract][Full Text] [Related]
14. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
[TBL] [Abstract][Full Text] [Related]
15. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
Deng JH; Zheng GY; Li HZ; Ji ZG
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
17. LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression.
Cai X; Zhang X; Mo L; Zhu J; Yu H
Cancer Biomark; 2020; 27(4):493-504. PubMed ID: 31958075
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539.
Wang R; Zheng B; Liu H; Wan X
Cell Cycle; 2020 May; 19(10):1122-1131. PubMed ID: 32286142
[TBL] [Abstract][Full Text] [Related]
19. LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma.
Guo R; Zou B; Liang Y; Bian J; Xu J; Zhou Q; Zhang C; Chen T; Yang M; Wang H; Pei F; Xu Z
Cell Death Dis; 2021 Jul; 12(7):689. PubMed ID: 34244473
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
